Prothegen Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Prothegen Inc. - overview
Established
2021
Location
Stanford, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2021, Prothegen Inc. operates as a biotechnology company. Davide Zanchi (CEO) and Scott Dixon are the co-founders of the company. In November 2021, Prothegen Inc raised an undisclosed amount in seed funding from new investor SOSV.
The company is a developer of a biotechnology platform aimed at delivering medicines for precisely regulating cell death. It develops drugs that stop cells from dying of ferroptosis, a way how cells die.
Current Investors
SOSV
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Prothegen Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.